Pfizer may build R&D centre in Hungary
This article was originally published in Scrip
Mario Gattino,Pfizer’s manager in Hungary, has said that the country has a good chance to host a new R&D centre to be set up by Pfizer with an estimated budget of $25-30 million. The centre would create 75-120 jobs, and a final decision on its location is expected this autumn. If approved, the centre might be built in the university city of Szeged, in southeast Hungary. The government supports the potential move, as supporting R&D is one of its priorities, Mr Gattino said. Several other countries in the region are competing for the centre.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.